DCF Advisers’s Immunogen Inc IMGN Stock Holding History

DCF Advisers’s Portfolio IMGN Stock Details IMGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-14,000	Closed	-$415K	–	95
2023 Q4	$415K	Buy	14,000 +1,150	+9%	+$22.9K	0.23%	61
2023 Q3	$204K	Buy	12,850 +2,500	+24%	+$41.6K	0.11%	85
2023 Q2	$195K	Buy	+10,350	New	+$122K	0.1%	81

Other funds holding IMGN

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Mather Group Chicago, Illinois $10B AUM 15.14% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

DCF Advisers's IMGN Position: Q1 2024 in Review

DCF Advisers sold out of Immunogen Inc (IMGN) in Q1 2024, closing a stake of 14,000 shares — an estimated $415K sold.

DCF Advisers first reported a position in IMGN in Q2 2023 and held it in 3 quarters. The position peaked at $415K in Q4 2023. 3 funds tracked by Wall St. Rank hold IMGN as of Q1 2024.

DCF Advisers reported no remaining Immunogen Inc position as of Q1 2024 after selling out during the quarter.
DCF Advisers sold 14,000 Immunogen Inc shares in Q1 2024, an estimated $415K.
DCF Advisers first reported a position in Immunogen Inc in Q2 2023 and held it in 3 quarters.
DCF Advisers's Immunogen Inc position peaked at $415K in Q4 2023.
3 funds tracked by Wall St. Rank held Immunogen Inc as of Q1 2024.

Based on DCF Advisers's 13F filing for Q1 2024, filed 15 May 2024.